How European Market Development Created Company Valuation to be held at the WSGR Campus in Palo Alto.
CoreValve has been a transatlantic med-tech venture . The innovation came from France, the company was established in the US, the initial development was done in Europe, and then finally was acquired by a US company. In this breakfast seminar we will have the opportunity to hear from two influential stakeholders in the CoreValve story. HealthCap Partner Johan Christenson, one of the European Investors and Board Members at CoreValve will speak about the ownership perspectives of why and how CoreValve developed the market in Europe. Following this, Rob Michiels, co-founder of CONSILIUM Associates, current CEO of CardiAQ™ Valve Technologies, and former COO and board member of CoreValve prior to its acquisition by Medtronic in 2009 will speak from the company perspective. He will also share some of his experience in evaluating market opportunities, accessing global markets and executing a global strategy to create market value. This will be followed by an update about the current reimbursement/market access perspectives of TAVI presented by Mattias Kyhlstedt from Synergus.
In conclusion Johan Christenson will lead a discussion, including a Q&A session, on how to build value in MedTech companies through a European execution strategy
Agenda:
7:30-8:00 Continental Breakfast
8:00 Introduction by Mattias Kyhlstedt, CEO of Synergus
8:05-8:30 CoreValve story from the perspective of a European investor
8:30-8:45 CoreValve story from the perspective of the company’s former COO
8:45-8:55 Current status of TAVI in Europe regarding Market Access and Reimbursement
8.55-9:15 Discussion on how to build value in MedTech companies through a European execution strategy
When & Where:
28th of October 7:30 AM – 9:15 AM
Location: Wilson Sonsini Goodrich & Rosati – Palo Alto Campus: 650 Page Mill Rd., Palo Alto, CA
Breakfast and the seminar are free of charge.
Space for this event is limited. To register your attendance, please click on the "register’ button above.
We want to thank Wilson Sonsini, Goodrich & Rosati for graciously providing both the venue and the breakfast for this event.
Bios:
Johan Christenson
Partner of HealthCap. Prior to joining Odlander Fredrikson in 2001 Dr Christenson was with SEB Företagsinvest (the venture capital arm of SEB) to supervise the health care portfolio. He has senior management experience from Astra Pain Control as Project director and AstraZeneca as Global Product Director and member of the global therapy area management team of Pain & Inflammation. He received his medical training at the Karolinska Institute and published his thesis in 1991 rendering him a Ph.D. in basic neuroscience. He served as a lecturer in neuroscience and is the author of 17 scientific articles. He held a position as assistant dean at the Karolinska Institute Graduate school for two years. Dr Christenson has four years of clinical specialist training in pediatrics and pediatric neurology.
Mattias Kyhlstedt
Founder and CEO of Synergus AB and Synergus Corp. Mattias has 15 years of experience in reimbursement, quality & regulatory in the medical device industry. He has unique management knowledge and insights within medical device companies based on previous positions within business development, production, quality, logistics and R&D in global corporations as well as start-ups. One of Europe’s most experienced consultants within pan-European reimbursement strategies and a frequent speaker at various international conferences in the area of reimbursement, quality, regulatory and clinical trials.